Detalhe da pesquisa
1.
Updated systematic review and network meta-analysis of first-line treatments for metastatic renal cell carcinoma with extended follow-up data.
Cancer Immunol Immunother
; 73(2): 38, 2024 Jan 30.
Artigo
Inglês
| MEDLINE | ID: mdl-38289361
2.
Prognostic impact of histological discordance between transurethral resection and radical cystectomy.
BJU Int
; 2024 Feb 12.
Artigo
Inglês
| MEDLINE | ID: mdl-38344879
3.
Survival outcome of chemotherapy-naïve castration-resistant prostate cancer treated with new-generation androgen receptor axis-targeted agents in real-world analysis.
Int J Clin Oncol
; 29(2): 213-221, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38103156
4.
Association between comorbidities and survival in patients with metastatic urothelial carcinoma treated with pembrolizumab.
Int J Clin Oncol
; 29(5): 612-619, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38430304
5.
Effectiveness and safety of enzalutamide and apalutamide in the treatment of patients with non-metastatic castration-resistant prostate cancer (nmCRPC): a multicenter retrospective study.
Int J Clin Oncol
; 2024 May 20.
Artigo
Inglês
| MEDLINE | ID: mdl-38769191
6.
Real world evidence of enfortumab vedotin in patients with advanced urothelial cancer: A multicenter observational study.
Int J Urol
; 31(4): 342-347, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38113343
7.
Adjuvant immunotherapy in patients with renal cell carcinoma and urothelial carcinoma: A systematic review and network meta-analysis.
Int J Urol
; 31(1): 25-31, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-37840031
8.
Prognostic significance of subclassifying pathological T3 upper tract urothelial carcinoma: Results from a multicenter cohort study.
Int J Urol
; 31(2): 125-132, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-37828777
9.
The clinical impact of ureteroscopy for upper tract urothelial carcinoma: A multicenter study.
Int J Urol
; 31(4): 394-401, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38151321
10.
Docetaxel versus abiraterone for metastatic hormone-sensitive prostate cancer with focus on efficacy of sequential therapy.
Prostate
; 83(6): 563-571, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36661102
11.
Effectiveness of pembrolizumab in trial-ineligible patients with metastatic urothelial carcinoma.
Cancer Immunol Immunother
; 72(4): 841-849, 2023 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-36102985
12.
Efficacy of Systemic Treatment in Prostate Cancer Patients With Visceral Metastasis: A Systematic Review, Meta-analysis, and Network Meta-analysis.
J Urol
; 210(3): 416-429, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37339479
13.
En Bloc Resection Versus Conventional TURBT for T1HG Bladder Cancer: A Propensity Score-Matched Analysis.
Ann Surg Oncol
; 30(6): 3820-3828, 2023 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-36897417
14.
Predicting Objective Response of Pembrolizumab in Platinum-Refractory Urothelial Carcinoma Based on NLR Fluctuation and Liver Metastases.
Oncology
; 2023 Oct 13.
Artigo
Inglês
| MEDLINE | ID: mdl-37839399
15.
Re-challenging chemotherapy after pembrolizumab in platinum-refractory urothelial carcinoma.
BJU Int
; 131(4): 477-485, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36098556
16.
Impact of sex on outcomes after surgery for non-muscle-invasive and muscle-invasive bladder urothelial carcinoma: a systematic review and meta-analysis.
World J Urol
; 41(4): 909-919, 2023 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-35963957
17.
Abiraterone acetate versus nonsteroidal antiandrogen with androgen deprivation therapy for high-risk metastatic hormone-sensitive prostate cancer.
Prostate
; 82(1): 3-12, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34559410
18.
Clinical benefit of continuing pembrolizumab treatment beyond progression in patients with metastatic urothelial carcinoma.
Cancer Immunol Immunother
; 71(1): 229-236, 2022 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-34100985
19.
The prognostic value of the preoperative lung immune prognostic index in patients with urothelial bladder cancer undergoing radical cystectomy.
Int J Clin Oncol
; 27(2): 396-402, 2022 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-34714458
20.
Prognostic role of the systemic immune-inflammation index in upper tract urothelial carcinoma treated with radical nephroureterectomy: results from a large multicenter international collaboration.
Cancer Immunol Immunother
; 70(9): 2641-2650, 2021 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-33591412